University of Texas Southwestern Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).

837 total trials 162 currently recruiting 503 completed early-phase tilt top decile by trial count

University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.

University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.

Top-decile sponsor footprint

University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

837 total, page 11 of 17

COMPLETED NA

Developing and Implementing an Adolescent Suicide Prevention Program in a Community Mental Health Setting

NCT03992391

COMPLETED NA

Hypothermia and the Effect of Ambient Temperature 2

NCT03008577

COMPLETED NA

Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient

NCT02774941

COMPLETED NA

Improving Chronic Disease Management With Pieces

NCT02587936

TERMINATED Phase 2

Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma

NCT02781506

COMPLETED Phase 2

13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF

NCT02786836

COMPLETED Phase 4

Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial

NCT02643381

COMPLETED NA

Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators

NCT02809677

COMPLETED

The Difficult Airway

NCT03671824

TERMINATED Phase 4

Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques?

NCT02788019

COMPLETED NA

End-of-Life Care for African Americans

NCT02320123

COMPLETED

Effects of Soft Tissue Lengthening on Gait in Children With Spasticity

NCT04090892

COMPLETED NA

Rotational Thromboelastometry Activated Transfusion In Trauma Trial

NCT03765866

COMPLETED NA

Increasing Physical Activity Among Breast Cancer Survivors With Depression

NCT02781051

COMPLETED

Thrombosis Outcomes in Pediatric Venous Thromboembolism

NCT03068923

COMPLETED NA

The Effects of Viscoelastometry Guided Resuscitation During Burn Excision on Post Resuscitation Infections

NCT03730415

TERMINATED NA

Low Level Laser Therapy With Physical Therapy for Chronic Musculoskeletal Pain

NCT02785432

COMPLETED NA

Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration

NCT02658240

COMPLETED NA

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination

NCT02537756

COMPLETED NA

DAILIES TOTAL1 Versus ACUVUE TruEye - Effects on the Biology of the Ocular Surface and Lid Margin

NCT02347631

COMPLETED

Cocaine Use and Outcomes of General Anesthesia

NCT02692534

TERMINATED Phase 2

LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma

NCT02524119

TERMINATED Phase 1

ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer

NCT02514031

COMPLETED Phase 4

Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)

NCT02739542

COMPLETED NA

7 Tesla MRI Study in Patients With Statin Related Muscle Complaints

NCT04575090

COMPLETED Phase 4

Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging

NCT02833415

TERMINATED Phase 4

Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study

NCT02717949

COMPLETED

UTSW Depression Cohort: A Longitudinal Study of Depression

NCT02697487

COMPLETED NA

Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Radiation for Breast Cancer

NCT02694029

COMPLETED NA

Increasing Physical Activity in Persons With Depression

NCT02781688

COMPLETED NA

Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants

NCT02372136

TERMINATED NA

Mechanisms of Muscle Blood Flow Dysregulation and Exercise Intolerance in Chronic Kidney Disease

NCT02664519

COMPLETED NA

Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery

NCT02561104

COMPLETED Phase 2

Orlistat for the Treatment of Type I Hyperlipoproteinemia

NCT02767531

COMPLETED Phase 3

Predictors of Depression Treatment Response to Exercise

NCT02583867

COMPLETED Phase 3

Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities

NCT02217501

TERMINATED Phase 2

Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma

NCT02513667

TERMINATED Phase 2

Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia

NCT01675154

TERMINATED NA

Mitochondrial Function in Patients With Severe Liver Disease

NCT02457702

COMPLETED Phase 4

Efficacy of Oral vs. Intravenous Acetaminophen

NCT02643394

COMPLETED

Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)

NCT02583815

COMPLETED

Corneal Sensitivity in Patients With Sleep Apnea Syndrome

NCT02265133

COMPLETED Phase 4

Phenytoin for Memory Impairment Secondary to Megestrol

NCT02595723

COMPLETED Phase 4

Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study

NCT02622568

COMPLETED NA

Negative Pressure Wound Therapy as a Drug Delivery System

NCT02463487

COMPLETED NA

Reduction of Radiation Dose and Contrast Use During Cryoballoon Pulmonary Vein Isolation

NCT03786822

COMPLETED NA

Improving Metabolic Health in Patients With Diastolic Dysfunction

NCT03448185

COMPLETED NA

Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease

NCT03476785

COMPLETED

Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis

NCT04025853

COMPLETED NA

Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients

NCT02485418

← Previous Page 11 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 106
Phase 2 122
Phase 3 28
Phase 4 98

What is open in the University of Texas Southwestern Medical Center pipeline

162 recruiting of 837 indexed (19% open); 503 completed (60%).

Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Hypertension (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Texas Southwestern Medical Center: open-pipeline peers nationwide

Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of Texas Southwestern Medical CenterUniversity of UtahUniversity of ChicagoIndiana UniversityDana-Farber Cancer InstituteCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalAnn & Robert H Lurie Children's Hospital of ChicagoVanderbilt University Medical Center
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 837 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Texas Southwestern Medical Center page

837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.

  • 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.